ANDRISANO, VINCENZA
 Distribuzione geografica
Continente #
NA - Nord America 13.682
EU - Europa 11.078
AS - Asia 5.406
AF - Africa 640
SA - Sud America 64
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 24
Totale 30.933
Nazione #
US - Stati Uniti d'America 13.617
GB - Regno Unito 2.932
IT - Italia 2.521
CN - Cina 2.202
DE - Germania 1.378
SG - Singapore 1.203
SE - Svezia 1.103
VN - Vietnam 960
UA - Ucraina 950
IN - India 651
FR - Francia 450
RU - Federazione Russa 429
IE - Irlanda 388
EE - Estonia 229
ZA - Sudafrica 204
CI - Costa d'Avorio 161
TG - Togo 150
BG - Bulgaria 117
CH - Svizzera 114
SC - Seychelles 86
FI - Finlandia 82
JO - Giordania 61
KR - Corea 55
ES - Italia 53
HR - Croazia 52
CA - Canada 50
BE - Belgio 48
JP - Giappone 43
NL - Olanda 40
EU - Europa 38
GR - Grecia 37
TR - Turchia 37
ID - Indonesia 35
IR - Iran 34
PL - Polonia 34
BR - Brasile 31
RO - Romania 27
CZ - Repubblica Ceca 26
AU - Australia 21
CL - Cile 20
NG - Nigeria 19
HK - Hong Kong 18
LB - Libano 17
DK - Danimarca 16
AT - Austria 14
TW - Taiwan 14
PK - Pakistan 13
MX - Messico 12
TH - Thailandia 11
PT - Portogallo 8
DZ - Algeria 7
IQ - Iraq 7
EG - Egitto 6
HU - Ungheria 6
MY - Malesia 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
MD - Moldavia 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BD - Bangladesh 4
CY - Cipro 4
EC - Ecuador 4
IL - Israele 3
LK - Sri Lanka 3
CM - Camerun 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SM - San Marino 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NC - Nuova Caledonia 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
Totale 30.933
Città #
Southend 2.620
Ashburn 1.360
Fairfield 1.323
Chandler 1.176
Singapore 1.039
Santa Clara 864
Houston 765
Wilmington 745
Jacksonville 659
Woodbridge 625
Dong Ket 619
Princeton 613
Bologna 559
Seattle 552
Ann Arbor 503
Cambridge 450
Boardman 399
Dublin 387
Nanjing 286
Westminster 268
Padova 264
Berlin 220
Jinan 187
Abidjan 161
Milan 156
Lomé 150
Shenyang 145
Medford 135
Saint Petersburg 130
Mülheim 112
Sofia 112
Beijing 107
Changsha 102
Falls Church 96
Turin 92
Nanchang 91
Hebei 90
New York 86
Mahé 83
Guangzhou 81
San Diego 80
Helsinki 77
Tianjin 75
Bern 74
Cesena 68
Amman 61
Dearborn 61
Jiaxing 60
Zhengzhou 59
Redmond 58
Rome 56
Bremen 55
Los Angeles 54
Des Moines 50
Haikou 50
Shanghai 49
Hangzhou 44
Norwalk 44
Hyderabad 42
Taiyuan 41
Redwood City 40
Verona 40
Brussels 39
Taizhou 39
Olalla 37
Forlì 36
Jakarta 29
Tokyo 28
Lanzhou 27
Phoenix 27
Fuzhou 26
Ningbo 26
San Giorgio di Piano 26
Kunming 24
Paris 24
Pune 24
Rimini 24
Cervia 22
Mountain View 22
Wuhan 21
Barcelona 20
London 20
Modena 19
Xi'an 19
Abeokuta 18
Bühl 18
Costa Mesa 18
Ottawa 18
Portogruaro 18
Florence 17
Hefei 16
Parma 15
Shenzhen 15
São Paulo 15
Mumbai 14
San Venanzo 14
Chicago 13
Fremont 13
Lausanne 13
Ravenna 13
Totale 20.477
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 468
A small molecule targeting the multifactorial nature of Alzheimer's disease 309
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 266
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 250
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 248
Analisi farmaceutica: metodi di riconoscimento e di separazione 240
null 222
Advanced analytical methodologies in Alzheimer's disease drug discovery 222
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: structure-based design, synthesis, and biological evaluation 210
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 197
Analisi farmaceutica. Metodi di riconoscimento e di separazione 189
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 183
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 180
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 176
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 167
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 164
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer’s Disease 159
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 158
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 155
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues 153
Rational Approach to discover multipotent anti-Alzheimer drugs 152
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 151
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 151
AFM study of F-actin on chemically modified surfaces 149
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 148
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 148
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 147
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 147
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 146
INFLUENCE OF AN INNOVATIVE, BIODEGRADABLE MULTILAYER ACTIVE PACKAGING ON “PESTO” SAUCE CHARACTERISTICS DURING STORAGE 145
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 144
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 144
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 140
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 140
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 139
AFM study of F-actin on chemically modified surfaces 138
Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action 138
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases 138
Determination of dextromethorphan and levomethorphan in seized heroin samples by enantioselective HPLC and electronic CD 138
Choosing the right chromatographic support in making a new acetylcholinesterase-micro-immobilised enzyme reactor for drug discovery. 136
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 135
null 135
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 134
Determination of levamisole and tetramisole in seized cocaine samples by enantioselective high-performance liquid chromatography and circular dichroism detection 134
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 134
Characterization of reversible and pseudo-irreversible Acetylcholinesterase inhibitors by means of immobilized enzyme reactor 132
Development of a new bio-compostable thin film for food packaging with in-line plasma treatment 132
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 131
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 131
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 129
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 129
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 129
Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets 127
Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. 127
Monolytic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies 125
Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorge 125
Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of Alzheimer's disease. 124
null 123
Simultaneous micellar electrokinetic chromatography of adriblastina and tarabine PFS. Their application to some biological fluids. 123
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks 123
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates 123
EcoPackLab: a new laboratory for the development of new food packaging with long shelf life 123
LC analysis of Oxytetracycline and Chlortetracycline: application for in vitro bio-equivalence study of veterinary medicines 122
Analytical approaches in Alzheimer’s disease Drug Discovery 122
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 122
Monolithic stationary phase coupled with coulometric detection: development of an ion-pair HPLC method for the analysis of quinone-bearing compounds. 121
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 121
Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors 121
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 121
GC-FID/MS method for the impurity profiling of synthetic d-allethrin. 119
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 119
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 119
CHOOSING THE RIGHT CHROMATOGRAPHIC SUPPORT FOR ENZYME-BASED MICRO-IMERS. 117
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 117
Characterization of Cholinesterase inhibitors by means of immobilized enzyme reactor 117
Micelles based on polyvinyl alcohol substituted with oleic acid for targeting of lipophilic drugs 117
Separation and quantitation of Fructose-6-phosphate and Fructose-1,6-diphosphate by LC-ESI-MS for the evaluation of Fructose-1,6-biphosphatase activity 116
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 116
Simultaneous separation and determination of Tarabine PFS and Adriblastine using micellar electrokinetic chromatography and high performance liquid chromatography. Application to some biological fluids 115
Batch-wise covalent immobilisation of human acetylcholinesterase: kinetic and inhibition spectrophotometric studies 115
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 115
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 114
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 114
Uleine disrupts key enzymatic and non-enzymatic biomarkers that leads to Alzheimer's disease 114
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease 114
Preparation of (hetero)aromatic (hetero)cyclic carboxamides for the treatment of Alzheimer's disease 113
Beta-secretase monolithic micro-IMER (immobilized enzyme reactor) for on-line HPLC screening of quinone-bearing polyamine inhibitors. 113
The role of Li(+), Na(+), and K(+) in the ligand binding inside the human acetylcholinesterase gorge 113
Heterocyclic inhibitors of AChE acylation and peripheral sites. 113
Human recombinant beta-secretase immobilized enzyme reactor for fast hits’ selection and characterization from a virtual screening library 113
Influence of high-pressure homogenization treatments combined with lysozyme activated packaging on microbiological and technological quality of vegetable smoothie during shelf life 112
Methotrexate determination in pharmaceuticals by enantioselective HPLC 112
Design, Synthesis and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease Modifying Agents for Alzheimer's Disease 112
APPLICATION OF AN IMMOBILIZED ENZYME REACTOR BASED ON HUMAN RECOMBINANT BETA-SECRETASE (HRBACE-1-IMER) FOR THE FAST SCREENING OF INHIBITORS 112
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease 112
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimers Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography 112
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 112
Stereoselective analysis of allethrin by two dimensional achiral/chiral HPLC with UV/circular dichroism detection 111
Circular dichroism investigation on amyloid bata(1-42) peptide self-aggregation 111
Multifunctional activity of some isoquinoline alkaloids from Corydalis cava tubers on Alzheimer's disease targets 111
Totale 14.413
Categoria #
all - tutte 80.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.800 0 0 0 0 0 0 752 929 835 537 340 407
2020/20214.247 900 296 91 230 74 244 85 404 376 218 226 1.103
2021/20225.246 495 188 279 319 456 339 130 385 278 405 1.032 940
2022/20235.517 588 736 308 723 376 391 143 348 910 230 466 298
2023/20242.500 123 295 174 205 190 367 270 403 72 123 157 121
2024/20254.296 325 1.038 712 466 1.351 357 47 0 0 0 0 0
Totale 31.704